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S-layer fusion proteins — construction principles
and applications
Nicola Ilk, Eva M Egelseer and Uwe B SleytrCrystalline bacterial cell surface layers (S-layers) are the
outermost cell envelope component of many bacteria and
archaea. S-layers are monomolecular arrays composed of a
single protein or glycoprotein species and represent the
simplest biological membrane developed during evolution. The
wealth of information available on the structure, chemistry,
genetics and assembly of S-layers revealed a broad spectrum
of applications in nanobiotechnology and biomimetics. By
genetic engineering techniques, specific functional domains
can be incorporated in S-layer proteins while maintaining the
self-assembly capability. These techniques have led to new
types of affinity structures, microcarriers, enzyme membranes,
diagnostic devices, biosensors, vaccines, as well as targeting,
delivery and encapsulation systems.
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In this article, a survey is given to more recent develop-
ments in applied S-layer research.
Introduction
Despite the considerable diversity among the cell envel-
ope structure of prokaryotic organisms, a common feature
is the presence of monomolecular arrays of protein or
glycoprotein species (Mw: 40–200 kDa) termed S-layers
[1]. S-layers have now been identified on organisms of
nearly every taxonomic group of walled bacteria and
represent an almost universal feature of archaea [2,3].
They exhibit either oblique (p1, p2), square (p4), or
hexagonal (p3, p6) symmetry (Figure 1) with unit cell
dimensions in the range of 3–30 nm. Depending on the
lattice symmetry, one morphological unit (unit cell) will
consist of one, two, three, four or six identical protein or
glycoprotein monomers. The crystalline arrays are gener-
ally 5–10 nm thick and represent highly porous protein
Open access under CC BY-NC-ND license. Current Opinion in Biotechnology 2011, 22:824–831 lattices (30–70% porosity) with pores of uniform size and
morphology in the 2–8 nm range. Moreover, S-layers are
highly anisotropic structures with respect to their topo-
graphy and physicochemical surface properties (for
review see [3]).
Despite the fact that considerable knowledge has been
accumulated on the genetics, morphogenesis, structure–
function relationship, and the biochemical and biophysical
properties of S-layer (glyco)proteins, no overall tertiary
structure of a native protein has been elucidated due to
the two-dimensional crystallization behavior of S-layer
proteins. Recently, a structural model of an S-layer protein,
namely the protein SbsB of Geobacillus stearothermophilus
PV72/p2 could be determined by means of molecular
dynamic simulations and small angle X-ray scattering [4,5].
Isolated S-layer proteins reassemble into regular arrays
upon removal of the disrupting agent (e.g. urea and gua-
nidine hydrochloride) used in the dissociation procedure.
The self-assembly products generated in suspension may
have the form of flat sheets, open-ended cylinders or closed
vesicles (for review see [6,7]). Most important for many
applications of S-layer lattices in nanobiotechnology and
biomimetics was the observation that S-layer proteins are
capable of reassembly into large coherent monolayers on
solid supports (e.g. metals, semiconductors, and polymers)
at the air/water interface and on Langmuir lipid films and
liposomes (for review see [7–9]).
Studies on a great variety of S-layers from Bacillaceae
revealed the existence of specific binding domains on the
N-terminal part of S-layer proteins for heteropolysacchar-
ides (secondary cell wall polymers; SCWPs) covalently
linked to the peptidoglycan matrix of the cell wall [10].
Most relevant, functionalizing surfaces with isolated
SCWP facilitates recrystallization of S-layers in defined
orientation which is of particular importance for nanobio-
technological applications.
Recombinant S-layer proteins
Although native S-layer proteins have already demon-
strated their great potential as patterning elements and
nanoscale building blocks, genetic approaches opened up
the possibility of modifying and changing the natural
properties of S-layer proteins thus leading to bio-inspired
materials with designed functional properties. However,
to be useful in nanobiotechnological applications, S-layer
proteins must be capable of tolerating insertions or
fusions with foreign proteins or domains, remaining able
to assemble into geometrically well-defined layers, and ofwww.sciencedirect.com
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Electron micrographs of freeze-etched preparations of intact cells from (a) Geobacillus stearothermophilus PV72/p2 exhibiting oblique (p1) lattice
symmetry, Bar, 50 nm, (b) Lysinibacillus sphaericus CCM 2177 showing a square (p4) lattice type, Bar, 150 nm, and (c) Thermoanaerobacter
thermohydrosulfuricus L111-69 showing hexagonal (p6) lattice symmetry, Bar, 100 nm. Inserts: schematic drawings of the different S-layer lattice
types. Depending on the lattice type, one morphological unit (shown in yellow) is composed of (a) one, (b) four, or (c) six identical subunits.incorporating a segment that has never participated in
lattice formation. To date, two different strategies for the
production of nanobiotechnologically relevant S-layer
fusion proteins are pursued, namely, homologous expres-
sion and secretion by the cells or production inside a host,
mostly Escherichia coli (Figure 2).
The most relevant advantages of the genetically engin-
eered S-layers over less nanostructured approaches are
the periodicity of functional domains in the nanometer
range on the outermost surface of the S-layer lattice and
the general applicability of the ‘S-layer tag’ to any fusion
partner. This leads to a high flexibility for variation of the
functional groups within a single S-layer array by cocrys-
tallization of different S-layer fusion proteins. On the
basis of results of recrystallization studies and surface
accessibility screens with various genetically produced N-
terminally and/or C-terminally truncated forms, the S-
layer proteins of several bacterial strains were chosen as
fusion partner for the construction of chimaeric S-layer
proteins (Table 1) [11–13].
S-layer based sensor technology and
diagnostics
Their intrinsic self-assembly properties as well as their
periodicity make S-layers ideal building blocks for all kindswww.sciencedirect.com of detection systems (DNA, protein or antibody chips as
well as label-free detection systems) (for review see [10]).
To generate a universal affinity matrix for binding of any
kind of biotinylated molecules (e.g. proteins, allergens,
antibodies or oligonucleotides), S-layer-streptavidin
fusion proteins carrying core-streptavidin either at the
N-terminal or C-terminal end have been constructed with
a great application potential in protein-chip, allergy-chip
or DNA-chip technology [14–16].
Another application potential can be seen in the devel-
opment of label-free detection systems. In the surface
plasmon resonance (SPR) or surface acoustic wave (SAW)
technique, specific binding of functional molecules (e.g.
proteins or antibodies) to the sensor chip functionalized
with an oriented chimaeric S-layer can be visualized
directly by a mass increase on the chip without the need
of any labeled compound. This was exemplified by the S-
layer fusion protein rSbpA31–1068/cAb-PSA carrying the
camel antibody sequence recognizing the prostate-
specific antigen (PSA) which was recrystallized on gold
chips precoated with thiolated SCWP [17]. The fused
ligands on the S-layer lattice showed a well-defined
spatial distribution down to the subnanometer scale,
which might reduce diffusion limited reactions [17,18].Current Opinion in Biotechnology 2011, 22:824–831
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Schematic drawing of technologies based on recombinant S-layer fusion proteins and their applications in nanobiotechnology.Another field of research deals with the production of S-
layer fusion proteins between the S-layer proteins of Ly.
sphaericus CCM 2177 or G. stearothermophilus PV72/p2 and
peptide mimotopes such as F1 that mimics an immuno-
dominant epitope of Epstein–Barr virus (EBV). Diagnos-
tic studies have been performed by screening 83
individual EBV IgM-positive, EBV-negative, and poten-
tial cross-reactive sera and resulted in 98.2% specificity
and 89.3% sensitivity as well as no cross-reactivity with
related viral diseases. This result demonstrates the poten-
tial of these S-layer fusion proteins to act as a matrix for
site-directed immobilization of small ligands in solid-
phase immunoassays [19].
A further line of development is the production of anti-
body-binding matrices based on chimaeric S-layers. For
that purpose, the S-layer fusion protein rSbpA31–1068/ZZ
incorporating two copies of the 58 amino acids long Fc-
binding Z-domain (a synthetic analogue of the IgG-bind-
ing domain of protein A from Staphylococcus aureus) wasCurrent Opinion in Biotechnology 2011, 22:824–831 constructed and the binding capacity for human IgG was
determined by SPR measurements [20]. By recrystalliza-
tion of this chimaeric protein on microbeads, a biocom-
patible matrix for the microsphere-based detoxification
system used for extracorporeal blood purification of
patients suffering from autoimmune disease has been
generated [20].
Vaccine development
Owing to their intrinsic adjuvant ability as well as their
capability to surface display proteins and epitopes,
S-layers are excellent candidates to be used as antigen
carriers, either as self-assembly products, recrystallized on
liposomes or displayed on bacteria.
On the basis of the fact that S-layer fusion proteins
comprising allergens combine reduced allergenicity with
immunomodulating capacity they can be considered as
novel approach to specific immunotherapy (SIT) of
allergic diseases [21–23]. This was exemplified by twowww.sciencedirect.com
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Table 1
Nanobiotechnological applications of recombinant S-layer fusion proteins
Application S-layer moiety Genetically fused functionality Length of function
Sensor technology and diagnostics SbpA, SbsB Core-streptavidin 118 aa
SbpA, SbsB Mimotope of Epstein–Barr virus (EBV) epitope F1 20 aa
SbpA ZZ, IgG-binding domain of Protein A 116 aa
SbpA cAb, Heavy chain camel antibody 117 aa
Vaccine development SbpA, SbsC Major birch pollen allergen (Bet v1) 116 aa
SbsA H. influenzae antigen (Omp26) 200 aa
SlpA Antigenic poliovirus epitope (VP1) 11 aa
SlpA Human c-myc proto-oncogene 10 aa
SLH-EA1, SLH-Sap Levansucrase of B. subtilis 473 aa
SLH-EA1 Tetanus toxin fragment C (ToxC) of C. tetani 451 aa
RsaA P. aeruginosa strain K pilin 12 aa
RsaA IHNV glycoprotein 184 aa
RsaA IgG-binding domain of Protein G GB1xs
RsaA Domain 1 of HIV receptor CD4 81 aa
RsaA MIP1a ligand for HIV coreceptor CCR5 70 aa
Immobilized biocatalysts SbpA Hyperthermophilic enzyme laminarinase (LamA) 263 aa
SgsE Glucose-1-phosphate thymidylyltransferase (RmlA) 299 aa
RsaA Beta-1,4-glycanase (Cex) 485 aa
Fluorescent biomakers SbpA Enhanced green fluorescent protein (EGFP) 238 aa 240 aa
SgsE Enhanced cyan fluorescent protein (ECFP) 240 aa
SgsE Enhanced green fluorescent protein (EGFP) 240 aa
SgsE Yellow fluorescent protein (YFP) 225 aa
SgsE Monomeric red fluorescent protein (RFP1)
Nanoparticle arrays SbpA Incorporated cysteine residues 3 aa
Biosorption of heavy metals RsaA His-tag, affinity tag 6 aa
S-layer proteins: SbsB of Geobacillus stearothermophilus PV72/p2, SbpA of Lysinibacillus sphaericus CCM 2177, SbsC of Geobacillus stear-
othermophilus ATCC 12980, SgsE of Geobacillus stearothermophilus NRS 2004/3a, SbsA of Geobacillus stearothermophilus PV72/p6, SlpA of
Lactobacillus brevis ATCC 8287, SLH (S-layer homology domain) of EA1 or Sap of Bacillus anthracis, RsaA of Caulobacter crescentus CB15A. For
review see [12,13,51].chimaeric S-layer proteins, rSbpA31–1068/Bet v1 and
rSbsC31–920/Bet v1, carrying the major birch allergen
Bet v1 at the C-terminus [22,23]. The recombinant
S-layer/Bet v1 fusion proteins altered an established
Th2-dominated phenotype as well as the de novo cytokine
secretion profile toward a more balanced Th1/Th0-like
phenotype [21,24,25]. This strategy may be generally
applied to design vaccines for SIT of type I allergy with
improved efficacy and safety.
Since up to now, the inability to establish viable Lacto-
bacillus S-layer null mutants has hampered the biotech-
nological applications of Lactobacillus S-layers, the
utilization of Lactobacillus brevis S-layer subunits (SlpA)
for the surface display of foreign antigenic epitopes was
envisaged [26]. In terms of immunological studies, an
inducible L. brevis expression system for the production,
secretion and surface display of antigenic epitopes
inserted at distinct sites of the S-layer protein SlpA
was developed [26]. While maintaining the S-layer lat-
tice structure, the 11-amino acid long epitope c-myc
from the human c-myc proto-oncogene was successfully
expressed in every S-layer subunit of the L. brevis S-layer
SlpA [26]. Delivery of antigens to mucosal surfaces
by lactic acid bacteria was considered to offer a safewww.sciencedirect.com alternative to live attenuated pathogens because of their
food grade status.
With the objective to deliver candidate antigens for the
development of vaccines against nontypeable Haemophi-
lus influenzae (NTHi) infections, the antigen Omp26 was
introduced at different positions of the S-layer protein
SbsA of G. stearothermophilus PV72/p6 [27]. The fusion
protein was expressed in empty bacterial cell envelopes,
so-called ghosts and induced an Omp26-specific antibody
response in BALB/c mice [28].
The gram-positive pathogen Bacillus anthracis, the causa-
tive agent of anthrax, which is a fulminant and lethal
infection of mammals, requires S-layer proteins for the
pathogenesis of infection [29]. Surface localization and
abundant expression of the S-layer protein BslA make this
polypeptide a candidate antigen for purified subunit
vaccines against B. anthracis [29]. In a former study, chi-
maeric genes encoding the sequence of the SLH-domains
of the two most abundant S-layer proteins, Sap or EA1, as
well as the levansucrase of Bacillus subtilis or the C fragment
of the tetanus toxoid of Clostridium tetani were cloned and
expressed in B. anthracis [30,31]. The fusion proteins were
secreted and could attach to the bacterial cell surface ofCurrent Opinion in Biotechnology 2011, 22:824–831
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ToxC, was used for veterinary vaccinal purposes [31].
A number of vaccine approaches involve the develop-
ment of vaccination vehicles, serving to potentiate
the immune response to an antigen. In this context,
the highly ordered S-layer structure [32,33] as well as
the C. crescentus RsaA secretion apparatus was exploited to
display foreign peptides on the C. crecentus cell surface.
The feasibility of the commercially available PurePro
TM Caulobacter expression and secretion system (Invi-
trogen) for the surface display of various functional epi-
topes (see Table 1) could already be demonstrated
[32,34–37]. This presentation system could have many
potential applications, such as the development of whole-
cell vaccines, tumor suppressors, cellular adsorbents, and
peptide display libraries [38–40].
Since Aeromonas hydrophila is an important fish pathogen
in aquaculture systems, there is an urgent need for a
potent vaccine to fight Aeromonas infections. A possible
reason why there is no commercial vaccine available can
be seen in the inability of these vaccines to cross-protect
against different isolates of A. hydrophila, which is a
biochemically as well as serologically heterogeneous bac-
terium [41]. The results of a recent study demonstrated
that the recombinantly produced S-layer protein of
A. hydrophila may be an important antigen for conferring
protection in common carp against a variety of virulent
isolates of this pathogenic bacterium [41].
A further recombinant subunit model vaccine was devel-
oped to fight infectious hematopoietic necrosis virus
(IHNV) which causes a hemorrhagic disease in young
salmonid fish. For that purpose, a 184-amino-acid seg-
ment of IHNV glycoprotein was fused to the C-terminal
portion of the C. crescentus S-layer protein and expressed
by the S-layer secretion system [37]. Investigations by
laboratory trials revealed a relative percent survival of
26–34% in rainbow trout fry [37].
Immobilized biocatalysts
Concerning the biotechnological application of
S-layer fusion proteins aiming at controllable display
of biocatalytic epitopes, storage stability, and reuse,
S-layer/enzyme fusion proteins comprising S-layer
proteins of Bacillaceae and enzymes from extremophilic
organisms (extremozymes) were cloned and expressed
in E. coli. For proof of principle, the enzyme b-1,3-
endoglucanase LamA from the extremophilic P. furiosus
was C-terminally fused to the S-layer protein SbpA31–
1068 of Ly. sphaericus CCM 2177 [42]. It is remarkable
to note that measured enzyme activities of the recrys-
tallized S-layer/enzyme fusion proteins reach up to
100% compared to the native enzyme. In a further
approach, S-layer/enzyme fusion proteins comprising
the glucose-1-phosphate thymidylyltransferase RmlACurrent Opinion in Biotechnology 2011, 22:824–831 from G. stearothermophilus NRS 2004/3a as well as the
SgsE derivatives SgsE31–773 or SgsE31–573 originating
from the same organism, were produced [43].
Recent research activities are focused on the production
of immobilized biocatalysts based on fusion proteins
comprising self-assembling S-layer proteins and multi-
meric enzymes of extremophiles (e.g. xylose isomerase of
Thermoanaerobacterium strain JW/SL-YS 489) (Ferner-Ort-
ner-Bleckmann, unpublished results).
Fluorescent biomarkers
In current studies, S-layer fusion protein technology was
used to build periodic biomimetic nanostructures with
controlled fluorescent properties [44,45].
The S-layer protein SgsE from G. stearothermophilus NRS
2004/3a was used for the production of four S-layer fusion
proteins carrying three different mutants of the green
fluorescent protein GFP and the red fluorescent protein
mRFP1 [44]. In addition, Kainz and coworkers reported
on the construction of a bifunctional S-layer tandem
fusion protein (ECFP–SgsE–YFP) which was able to
self-assemble on solid supports without losing its func-
tionality [45]. The results indicated that the assembling
and the fluorescence properties of the newly designed
fluorescent S-layer fusion proteins can be used for build-
ing nanopatterned biofunctional surfaces for future appli-
cations in nanobiotechnology, such as pH indicators both
in vivo and in vitro or as fluorescent markers for drug
delivery systems [44,45].
A further promising application potential can be seen in
the development of drug and delivery systems based on
liposome–DNA complexes coated with functional S-layer
fusion protein for transfection of eukaryotic cell lines. In
this context, the S-layer fusion protein rSbpA31–1068/
EGFP incorporating the sequence of enhanced green
fluorescent protein (EGFP) was recrystallized as a mono-
layer on the surface of positively charged liposomes thus
representing a useful tool to visualize the uptake of S-
layer coated-liposomes into eukaryotic cells [46].
Nanoparticle arrays
In soluble and recrystallized rSbpA/STII/Cys fusion
proteins, the short affinity tag for streptavidin, Strep-tag
II, was used for prescreening of the surface accessibility,
whereas the thiol group of the end-standing cysteine
residue was exploited for site-directed chemical linkage
of differently sized preactivated macromolecules via het-
erobifunctional cross-linkers [47]. Such functionalized
two-dimensional S-layer lattices formed by rSbpA/
STII/Cys exhibited highly accessible cysteine residues
in a well-defined arrangement on the surface and could be
utilized for the template-assisted patterning of gold nano-
particles [47].www.sciencedirect.com
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A current trend in the field of bioengineered materials is
to investigate the role of S-layer-carrying bacteria in the
biosorption of heavy metals [e.g. U, Cu, Pd(II), and
Au(III)] [48,49]. Recently, the genetically engineered
S-layer protein RsaA was employed as a delivery system
for displaying hexa-histidine peptides on the Caulobacter
cell surface and to construct a recombinant bioremedia-
tion agent to remove cadmium from contaminated water
samples [50].
Conclusions
Data obtained in studies on the structure, chemistry,
genetics, morphogenesis, and function demonstrated
that S-layers are the simplest protein membranes
developed during evolution. Their structure and physi-
cochemical repetitive uniformity down to the subnan-
ometer scale has already led to numerous applications in
nanobiotechnology and biomimetics. Most important,
S-layers represent very versatile self-assembly systems
which can be exploited as structural basis for a complete
supramolecular construction kit, involving all major
species of biological macromolecules (e.g. proteins,
lipids, glycans, nucleic acids, and combinations of
these). Moreover, the possibility to modify the natural
properties of S-layer proteins by genetic manipulations
and to incorporate single or multifunctional domains of
other proteins while maintaining the self-assembly capa-
bility has led to a broad spectrum of applications in
numerous areas of both, life and material sciences.
Another area of future development concerns copying
the supramolecular principle of cell envelopes of archaea.
The observation that S-layers can be used as supporting
and stabilizing structures for lipid membranes incorpor-
ating functional molecules will lead to applications in
sensor technology, diagnostics, nanobiotechnology,
electronic or optical devices, and high-throughput screen-
ing for drug discovery (for reviews see [6,7,10,12,51,
52,53]).
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